基于 4 个已确定 T+90 收益的买入信号。收益基准:公布次日的收盘价。
Browse the complete record of transactions filed by Weaver Gregory l, 首席财务官. Director active across 3 companies, notably ATAI Life Sciences N.V.. In total, 9 disclosures have been logged. Split: 5 buys · 1 sell. Total volume traded: €223k. Activity tracked since 22 June 2021. The latest transaction was disclosed on 31 July 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 条申报中的 9 条
WEAVER GREGORY L is Directeur Financier. The record shows 9 filings in total, and across the 9 sampled filings the activity runs from 2021-06-24 to 2026-08-03, with EUR 193234 of buys and EUR 29876 of sells, mainly under the transaction nature Acquisition.